1. Home
  2. RVMD vs GFS Comparison

RVMD vs GFS Comparison

Compare RVMD & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$142.49

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Logo GlobalFoundries Inc.

GFS

GlobalFoundries Inc.

HOLD

Current Price

$64.53

Market Cap

24.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
GFS
Founded
2014
2009
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
19.2B
24.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RVMD
GFS
Price
$142.49
$64.53
Analyst Decision
Strong Buy
Buy
Analyst Count
19
12
Target Price
$140.84
$45.08
AVG Volume (30 Days)
3.7M
3.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.64
Revenue Next Year
$533.02
$9.90
P/E Ratio
N/A
$29.28
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$31.51
52 Week High
$155.70
$65.05

Technical Indicators

Market Signals
Indicator
RVMD
GFS
Relative Strength Index (RSI) 64.03 78.45
Support Level $93.39 $32.53
Resistance Level $155.70 N/A
Average True Range (ATR) 7.73 2.57
MACD -0.26 0.90
Stochastic Oscillator 55.23 96.83

Price Performance

Historical Comparison
RVMD
GFS

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.

Share on Social Networks: